| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.01 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.01 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |